Source: Annual Congress 2002 - Acute exacerbations of COPD: aetiology and therapy
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. G. S. Stoica (Bucharest, Romania). COPD exacerbation etiological and therapeutically aspects. Eur Respir J 2002; 20: Suppl. 38, 3367

Member's Comments

No comment yet.

Related content which might interest you: The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Some aspects of COPD ethiopathogenesis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Endocrinopathies and related with COPD exacerbation Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 The role of IFN-γ in severe COPD patients with anamnestic viral-induced exacerbations before and after roflumilast treatment Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Antibiotics in acute exacerbation of asthma and COPD Source: Eur Respir Monogr 2017; 75: 150-158 Year: 2017 Clinical characteristics and prognostic features in infectious and non-infectious COPD exacerbations Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Characteristics of bronchial brush-biopsies at different etiology of COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 410s Year: 2004 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Defining the contribution of emphysema and chronic bronchitis in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014